247 related articles for article (PubMed ID: 15533212)
1. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels.
Tsai CH; Yang SF; Chen YJ; Chu SC; Hsieh YS; Chang YC
Oral Dis; 2004 Nov; 10(6):360-4. PubMed ID: 15533212
[TBL] [Abstract][Full Text] [Related]
2. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
3. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
4. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline.
Yang SF; Tsai CH; Chang YC
J Oral Pathol Med; 2008 Apr; 37(4):206-10. PubMed ID: 18221324
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
6. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
7. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
8. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
9. Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis.
Tsai CH; Yang SF; Lee SS; Chang YC
Oral Dis; 2009 May; 15(4):281-6. PubMed ID: 19388153
[TBL] [Abstract][Full Text] [Related]
10. The upregulation of cystatin C in oral submucous fibrosis.
Chung-Hung T; Shun-Fa Y; Yu-Chao C
Oral Oncol; 2007 Aug; 43(7):680-5. PubMed ID: 17070095
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline.
Ho YC; Yang SF; Lee SS; Chang YC
J Formos Med Assoc; 2017 Jun; 116(6):484-487. PubMed ID: 28365254
[TBL] [Abstract][Full Text] [Related]
12. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
13. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
14. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
[TBL] [Abstract][Full Text] [Related]
16. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
[TBL] [Abstract][Full Text] [Related]
17. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
[TBL] [Abstract][Full Text] [Related]
18. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
19. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
20. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
